--- title: "Curaleaf Holdings, Inc. (CURLF.US)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/CURLF.US.md" symbol: "CURLF.US" name: "Curaleaf Holdings, Inc." industry: "Pharmaceuticals" datetime: "2026-05-20T05:58:55.347Z" locales: - [en](https://longbridge.com/en/quote/CURLF.US.md) - [zh-CN](https://longbridge.com/zh-CN/quote/CURLF.US.md) - [zh-HK](https://longbridge.com/zh-HK/quote/CURLF.US.md) --- # Curaleaf Holdings, Inc. (CURLF.US) ## Company Overview Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. | Item | Detail | |------|--------| | Industry | Pharmaceuticals | | Exchange | US Market | | Website | [www.curaleaf.com](https://www.curaleaf.com) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: D > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-05-20T04:30:15.000Z **Overall: D (0.66)** **Industry**: Pharmaceuticals | Metric | Value | |--------|-------| | Industry Ranking | 127 / 190 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock. **Multi Score**: D #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -1.25% | | | Net Profit YoY | 50.97% | | | P/B Ratio | 3.00 | | | Dividend Ratio | 0.00% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 2464851289.74 | | | Revenue | 1285742000.00 | | #### Multi Score Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -13.85% | E | | Profit Margin | -7.79% | D | | Gross Margin | 48.51% | B | | Revenue YoY | -1.25% | D | | Net Profit YoY | 50.97% | B | | Total Assets YoY | -4.61% | D | | Net Assets YoY | -5.61% | D | | Cash Flow Margin | -92.83% | E | | OCF YoY | -1.25% | D | | Turnover | 0.45 | C | | Gearing Ratio | 67.67% | D | ```chart-data:radar { "title": "Longbridge Financial Score - Curaleaf Holdings, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "-1.25%", "rating": "" }, { "name": "Net Profit YoY", "value": "50.97%", "rating": "" }, { "name": "P/B Ratio", "value": "3.00", "rating": "" }, { "name": "Dividend Ratio", "value": "0.00%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "2464851289.74", "rating": "" }, { "name": "Revenue", "value": "1285742000.00", "rating": "" } ] }, { "name": "Multi Score", "grade": "D", "indicators": [ { "name": "ROE", "value": "-13.85%", "rating": "E" }, { "name": "Profit Margin", "value": "-7.79%", "rating": "D" }, { "name": "Gross Margin", "value": "48.51%", "rating": "B" }, { "name": "Revenue YoY", "value": "-1.25%", "rating": "D" }, { "name": "Net Profit YoY", "value": "50.97%", "rating": "B" }, { "name": "Total Assets YoY", "value": "-4.61%", "rating": "D" }, { "name": "Net Assets YoY", "value": "-5.61%", "rating": "D" }, { "name": "Cash Flow Margin", "value": "-92.83%", "rating": "E" }, { "name": "OCF YoY", "value": "-1.25%", "rating": "D" }, { "name": "Turnover", "value": "0.45", "rating": "C" }, { "name": "Gearing Ratio", "value": "67.67%", "rating": "D" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -19.03 | 207/190 | - | - | - | | PB | 3.00 | 117/190 | 2.64 | 2.33 | 1.35 | | PS (TTM) | 1.92 | 51/190 | 1.74 | 1.48 | 0.84 | | Dividend Yield | 0.00% | - | - | - | - | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | Cormedix (CRMD.US) | A | A | B | C | B | A | | 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B | | 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B | | 04 | Roche (RHHBY.US) | A | B | B | D | B | B | | 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B | ## Institutional View ### Analyst Rating Distribution > As of 2026-05-08T04:00:00.000Z Total Analysts: **7** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 6 | 86% | | Overweight | 1 | 14% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 3.22 | | Highest Target | 5.00 | | Lowest Target | 4.00 | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CURLF.US/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CURLF.US/norm.md) - [Related News](https://longbridge.com/en/quote/CURLF.US/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CURLF.US/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**